Fatigue after COVID-19 in non-hospitalized patients according to sex 2023 Mazurkiewicz et al

Discussion in 'Long Covid research' started by Andy, Jan 9, 2023.

  1. Andy

    Andy Committee Member

    Messages:
    22,407
    Location:
    Hampshire, UK
    Abstract

    Background
    Limited evidence exists on sex differences in post-COVID fatigue among non-hospitalized patients. Therefore, aim of the study was to evaluate the course of chronic fatigue symptoms in non-hospitalized subjects with the SARS-CoV-2 infection, according to sex.

    Methods
    Patients and staff from the University Hospital in Krakow anonymously and retrospectively completed neuropsychological questionnaire that included eight symptoms of chronic fatigue syndrome. The presence of these symptoms was assessed before COVID-19 and 0–4, 4–12, and >12 weeks postinfection. The inclusion criteria were as follows: age 18 or more years, >12 weeks since the onset of the SARS-CoV-2 infection, and diagnosis confirmed by the RT-PCR from anasopharyngeal swab.

    Results
    We included 303 patients (79.53% women, 47.52% medical personnel) assessed retrospectively after a median of 30 (interquartile range: 23–35) weeks since the onset of symptoms. A higher prevalence of at least one chronic fatigue symptom was found in females in all time intervals after the onset of COVID-19 compared to males (p < .036). Women, compared to men, more often experienced persistent fatigue, not caused by effort and persisting after rest (for <4 weeks, odds ratio [OR] = 2.31, 95% confidence interval [CI]: 1.13–4.73; for 4–12 weeks, OR = 1.95, 95% CI: 1.06–3.61), non-restorative sleep (for <4 weeks, OR = 2.17, 95% CI: 1.23–3.81; for >12 weeks, OR = 1.95, 95% CI: 1.03–3.71), and sore throat (for <4 weeks, OR = 1.97, 95% CI: 1.03–3.78; for 4–12 weeks, OR = 2.76, 95% CI: 1.05–7.27). Sex differences in headache, arthralgia, and prolonged postexercise fatigue were observed only during the first 4 weeks (OR = 2.59, 95% CI: 1.45–4.60, OR = 2.97, 95% CI: 1.02–8.64, and OR = 1.87, 95% CI: 1.01–3.51, respectively). There were no differences between women and men in myalgia and self-reported lymph node enlargement.

    Conclusions
    The course of post-COVID fatigue differs significantly between sexes in non-hospitalized individuals with COVID-19, with women more often suffering from persistent fatigue, not caused by effort and persisting after rest, non-restorative sleep, and sore throat.

    Open access, https://onlinelibrary.wiley.com/doi/10.1002/brb3.2849
     
    RedFox and Peter Trewhitt like this.
  2. Andy

    Andy Committee Member

    Messages:
    22,407
    Location:
    Hampshire, UK
    They identified 'PEM' with...

    "Did you experience problems with: Prolonged postexercise fatigue"
     
  3. RedFox

    RedFox Senior Member (Voting Rights)

    Messages:
    1,270
    Location:
    Pennsylvania
    That might be "good enough" here.
     
    alktipping and Peter Trewhitt like this.
  4. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    13,008
    Location:
    Canada
    Ugh. It's bad enough that most studies are entry-level, but the mass of remedial-level junk is just absurd at this point.

    None of those researchers would even pass a basic quiz on what ME is. How do they figure out that they can research something when they don't even bother learning about what it is?

    Ah, right, they're allowed to and no one in a leadership position cares. Somehow. Just great.
     
    alktipping and Peter Trewhitt like this.

Share This Page